"A Study of the Feasibility of Using the Dietary Supplement ARTNEO in Patients With Osteoathritis"

NACompletedINTERVENTIONAL
Enrollment

212

Participants

Timeline

Start Date

May 31, 2022

Primary Completion Date

February 28, 2023

Study Completion Date

April 17, 2023

Conditions
Osteoarthritis, KneeOsteoarthritisKnee OsteoarthritisKnee ArthritisKnee DiscomfortKnee Pain SwellingKnee Pain Chronic
Interventions
DIETARY_SUPPLEMENT

undenaturated collagen type II, methylsulfonylmethane, boswellia serrata, vitamin D3 (cholecalciferol), vitamin C (ARTNEO)

"Release form: capsules with an average weight of 585 mg. Active ingredients: MCM (methylsulfonylmethane) 300 mg, vitamin C (ascorbic acid) 80 mg, boswellia extract (65% boswellic acids) 50.05 mg, undenatured (native) type II collagen 40 mg, vitamin D3 (cholecalciferol) 400 IU.~Suggested Use: Adults, 1 capsule daily with meals."

DIETARY_SUPPLEMENT

Placebo

Release form: capsules with an average weight of 585 mg. No active ingredients.

Trial Locations (12)

115522

"Federal State Budgetary Scientific Institution Research Institute of Rheumatology named after V.A. Nasonova", Moscow

117997

Pirogov Russian National Research Medical University, Moscow

191119

Research Center Eco-Safety LLC, Saint Petersburg

194156

Energiia Zdoroviya LLC, Saint Petersburg

196066

"Medical Sanitary Unit No. 157 LLC", Saint Petersburg

196143

Research Center Eco-Safety LLC, Saint Petersburg

196158

Zvezdnaya Clinic LLC, Saint Petersburg

199397

Meili LLC, Saint Petersburg

300053

"State Health Institution Tula Regional Clinical Dermatovenerologic Dispensary", Tula

420097

NIMK Vashe Zdorovie LLC, Kazan'

432017

Ulyanovsk Regional Clinical Hospital, Ulyanovsk

Unknown

Private educational institution of additional professional education 'Institute for advanced training and professional retraining of personnel, Yaroslavl

All Listed Sponsors
lead

NPO Petrovax

INDUSTRY